Wytwórnia Surowic I Szczepionek Biomedsp. z o.o.
Manufacture of pharmaceutical preparations
Overview
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $190,276 |
Filing timeliness
Financial statements were filed on time, on average 43 days early. All were audited by a statutory auditor.
- 2025filed
- 202429/05/2025
- 202309/07/2024
- 202201/07/2023
- 202122/06/2022
- 202014/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Sanctions and PEP lists
| Person | List | Match | |
|---|---|---|---|
| Michał Bolesław Pniewski | Członek organu spółki Skarbu Państwa | confirmed |
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Public procurement
3 tenders recorded as contractor: 1 national ($53,336) and 2 EU ($1,088,005).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Aug 3, 2026 | Supply of botulinum toxin antiserum under the grant project “Development and maintenance of rescEU medical stockpiles in Poland” | $1.1M$1,075,916 | Rządowa Agencja Rezerw Strategicznych | |
| Dec 18, 2025 | Supply of a medicinal product containing streptodornase and streptokinase (...) | $53,336$53,336 | Rządowa Agencja Rezerw Strategicznych | |
| Sep 12, 2024 | Purchase and delivery of medicinal products, ophthalmic products, viscoelastic materials, continuous renal replacement therapy sets and dialysis equipment. | $12,090$12,090 | Wojewódzki Szpital Podkarpacki Im. Jana Pawła II w Krośnie |
Trademarks
Wytwórnia Surowic I Szczepionek Biomed holds 2 active trademarks registered with the Polish Patent Office. 16 marks have expired or were not registered. The first mark was filed in 1993.
| Mark | Protected until | |
|---|---|---|
| BIOSTREPTA(word) | Jan 17, 2029 | |
| SIS BIOMED | Jun 2, 2033 | |
| BIOSTREPTA(word) | – | |
| BIOSTREPTA(word) | – | |
| BIOSTREPTAZA(word) | – |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the company may be represented and declarations of will may be made on behalf of the company by two members of the management board jointly, one member of the management board jointly with a commercial proxy, or two commercial proxies jointly. If the management board is a one-person management board, declarations of will on behalf of the company may be made by one member of the management board or by a commercial proxy who has been granted independent commercial power of procuration.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
'%3e%3cpath%20d='M256%20512C397.385%20512%20512%20397.385%20512%20256C512%20114.615%20397.385%200%20256%200C114.615%200%200%20114.615%200%20256C0%20397.385%20114.615%20512%20256%20512Z'%20fill='%23F0F0F0'/%3e%3cpath%20d='M512%20256C512%20397.384%20397.384%20512%20256%20512C114.616%20512%200%20397.384%200%20256'%20fill='%23D80027'/%3e%3c/g%3e%3cdefs%3e%3cclipPath%20id='clip0_4_7258'%3e%3crect%20width='512'%20height='512'%20fill='white'/%3e%3c/clipPath%3e%3c/defs%3e%3c/svg%3e) Skarb Państwa Reprezentowany przez Ministra Skarbu Państwa | 486,640 | $6,572,663.43 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1996-01-01.
11 1050 1025 1000 0090 8425 3591- 39 1050 1025 1000 0090 8453 9528
- 31 1050 1025 1000 0090 8453 9478
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 933.9KPLN 933,889 |
Public aid
9 public aid cases recorded, with a total value of $1,038,324.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 25, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $14,358$14,358 | Prezydent Miasta Stołecznego Warszawy | |
| Apr 23, 2025 | Aid for research and development projects: industrial research | $655.7K$655,727 | Prezes Agencji Badań Medycznych | |
| Sep 22, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $37,540$37,540 | Prezydent Miasta Stołecznego Warszawy |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | Integrated permit | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
Change history
| Date | Event | |
|---|---|---|
| 2015-08-21 | Switch to PKD 2007 (15 PKD 2004 codes → 10 PKD 2007 codes) | |
| 2007-08-24 | Entered in the register |
FAQ
Last updated: 2026-10-07